O. López-Godino

发表

Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome.

F. Sánchez-Guijo, C. del Cañizo, D. Caballero, 2015, Leukemia research.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

P. Ljungman, M. Remberger, O. Ringdén, 2018, Medical Oncology.

Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology

J. Cervera, E. Such, M. Díez-Campelo, 2018, International journal of laboratory hematology.

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

C. Solano, L. Bento, M. Bastos-Oreiro, 2022, Cancers.

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

G. Gutiérrez-García, C. Solano, J. Pérez-Simón, 2021, Bone Marrow Transplantation.

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.

J. Briones, C. Grande, I. Jarque, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Transplant in Relapsed or Refractory Aggressive B-Cell Lymphoma: a GELTAMO Trial

J. Briones, C. Grande, I. Jarque, 2016 .

Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms

F. Sánchez-Guijo, J. Pérez-Simón, M. Alcoceba, 2019, Clinical Cancer Research.

Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial

F. Sánchez-Guijo, A. Carrillo-Vico, J. Pérez-Simón, 2016, Clinical Cancer Research.

Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model: Prognostication in myelofibrosis.

F. Sánchez-Guijo, Arturo Pereira, J. Mora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

J. Perkins, C. Solano, J. Pidala, 2017, Bone Marrow Transplantation.

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving graft versus host disease prophylaxis with tacrolimus plus methotrexate or sirolimus

J. Miguel, J. González-Porras, F. Sánchez-Guijo, 2016 .

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

J. González-Porras, F. Sánchez-Guijo, J. Pérez-Simón, 2014, Bone Marrow Transplantation.

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.

E. Ocio, J. S. San Miguel, J. Pérez-Simón, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

S. Rives, J. M. Fernández, M. Ramírez, 2020, British journal of haematology.

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

C. Solano, F. Sánchez-Guijo, J. Pérez-Simón, 2016, Bone Marrow Transplantation.

Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors

J. Sanz, L. Bento, A. Jiménez-Ubieto, 2020, Bone Marrow Transplantation.

Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC.

C. Solano, J. Sanz, L. Bento, 2022, Transplantation and cellular therapy.

Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma

M. Mateos, C. del Cañizo, L. Lopez-Corral, 2015, Clinical case reports.

Identification of Circulating microRNA Signatures As Potential Noninvasive Biomarkers for Prediction to Response to Extracorporeal Photoapheresis in Patients with Graft Versus Host Disease

N. García-Barberá, C. Martínez, C. Perotti, 2019, Blood.